| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Oct 03, 2022 | Option Exercise | $148.50 | 5,068 | 752,598 | 1,614 | Oct 03, 2022, 08:27 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Oct 03, 2022 | Option Exercise | $148.50 | 1,614 | 239,679 | 0 | Oct 03, 2022, 08:27 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Jan 06, 2022 | Option Exercise | $123.86 | 551 | 68,247 | 4,404 | Jan 07, 2022, 09:18 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Jan 07, 2022 | Option Exercise | $128.87 | 342 | 44,074 | 4,937 | Jan 07, 2022, 09:18 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Nov 25, 2021 | Option Exercise | $115.55 | 492 | 56,851 | 3,417 | Nov 26, 2021, 04:33 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Jan 06, 2021 | Option Exercise | $83.38 | 492 | 41,023 | 2,659 | Jan 08, 2021, 08:49 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Nov 25, 2020 | Option Exercise | $90.14 | 480 | 43,267 | 1,540 | Nov 27, 2020, 09:48 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Jun 10, 2020 | Sale | $38.34 | 104,000 | 3,987,080 | 52,770 | Jun 12, 2020, 05:19 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | CCO-Rare & Neurologic Disorder | Dec 18, 2019 | Option Exercise | $52.13 | 480 | 25,022 | 770 | Dec 20, 2019, 09:41 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Mar 12, 2019 | Sale | $29.70 | 20,000 | 594,000 | 10,000 | Mar 14, 2019, 05:51 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Jan 10, 2019 | Sale | $23.48 | 21,000 | 493,080 | 10,500 | Jan 14, 2019, 05:50 PM | |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Tilton John | Chief Commercial Officer | Nov 01, 2017 | Sale | $19.27 | 60,000 | 1,156,286 | 30,000 | Nov 02, 2017, 05:55 PM |
Menu